Structure-activity relationship of cyclic thiacarbocyanine tau aggregation inhibitors

Cited 7 time in webofscience Cited 0 time in scopus
  • Hit : 266
  • Download : 14
DC FieldValueLanguage
dc.contributor.authorSchafer, Kelsey N.ko
dc.contributor.authorMurale, Dhiraj Padmakarko
dc.contributor.authorKim, Ki-Bongko
dc.contributor.authorCisek, Katrynako
dc.contributor.authorKuret, Jeffko
dc.contributor.authorChurchill, David Gko
dc.date.accessioned2013-03-11T04:34:14Z-
dc.date.available2013-03-11T04:34:14Z-
dc.date.created2012-02-06-
dc.date.created2012-02-06-
dc.date.issued2011-06-
dc.identifier.citationBIOORGANIC MEDICINAL CHEMISTRY LETTERS, v.21, no.11, pp.3273 - 3276-
dc.identifier.issn0960-894X-
dc.identifier.urihttp://hdl.handle.net/10203/98261-
dc.description.abstractMacrocyclic bis-thiacarbocyanines are efficacious inhibitors of tau protein aggregation. To extend the structure-activity relationship of this inhibitor class, N,N'-alkylene bis-thiacarbocyanines linked by chains of three to eight methylene carbons were synthesized and examined for inhibitory activity against recombinant human tau aggregation in vitro. At 10 micromolar concentration, inhibitory activity varied with linker length, with four methylene units being most efficacious. On the basis of absorbance spectroscopy measurements, linker length also affected compound folding and aggregation propensity, with a linker length of four methylene units being optimal for preserving open monomer conformation. These data suggest that inhibitory potency can be optimized through control of linker length, and that a contributory mechanism involves modulation of compound folding and aggregation. (C) 2011 Elsevier Ltd. All rights reserved.-
dc.languageEnglish-
dc.publisherPERGAMON-ELSEVIER SCIENCE LTD-
dc.subjectFILAMENT FORMATION-
dc.subjectPOTENT INHIBITION-
dc.subjectFIBRILLIZATION-
dc.subjectLIGAND-
dc.subjectDYE-
dc.titleStructure-activity relationship of cyclic thiacarbocyanine tau aggregation inhibitors-
dc.typeArticle-
dc.identifier.wosid000290708300016-
dc.identifier.scopusid2-s2.0-79956061251-
dc.type.rimsART-
dc.citation.volume21-
dc.citation.issue11-
dc.citation.beginningpage3273-
dc.citation.endingpage3276-
dc.citation.publicationnameBIOORGANIC MEDICINAL CHEMISTRY LETTERS-
dc.embargo.liftdate9999-12-31-
dc.embargo.terms9999-12-31-
dc.contributor.localauthorChurchill, David G-
dc.contributor.nonIdAuthorSchafer, Kelsey N.-
dc.contributor.nonIdAuthorCisek, Katryna-
dc.contributor.nonIdAuthorKuret, Jeff-
dc.type.journalArticleArticle-
dc.subject.keywordAuthorAlzheimer&apos-
dc.subject.keywordAuthors disease-
dc.subject.keywordAuthorTau protein-
dc.subject.keywordAuthorNeurofibrillary tangle-
dc.subject.keywordAuthorCyanine dye-
dc.subject.keywordAuthorAggregation-
dc.subject.keywordPlusFILAMENT FORMATION-
dc.subject.keywordPlusPOTENT INHIBITION-
dc.subject.keywordPlusFIBRILLIZATION-
dc.subject.keywordPlusLIGAND-
dc.subject.keywordPlusDYE-
Appears in Collection
CH-Journal Papers(저널논문)
Files in This Item
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡ Click to see webofscience_button
⊙ Cited 7 items in WoS Click to see citing articles in records_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0